Status:
UNKNOWN
Briagen Observational Study
Lead Sponsor:
Gemstone Biotherapeutics
Conditions:
Mohs Surgery
Eligibility:
All Genders
18+ years
Brief Summary
This research study is evaluating a study product called Briagen™ as a possible treatment for wound healing after Mohs procedure.
Detailed Description
Briagen, the study product being used in this study, is a natural complex carbohydrate wound dressing for skin wounds created by Mohs surgery. Briagen was developed with the intent to improve healing...
Eligibility Criteria
Inclusion
- Patient seeking treatment for wound created by Mohs or other full thickness skin excisions
- Over 18 years of age
- English-speaking
- Presents for treatment within 24 hours of initial Mohs skin excision procedure.
Exclusion
- History of significant wound complications and non-compliance on wound maintenance instructions (infections, disturbing the wound during the healing process, etc.)
- Known diagnosis of Diabetes
- Active infection in the wound bed
- Under 18 years of age
Key Trial Info
Start Date :
August 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04090970
Start Date
August 26 2019
End Date
May 1 2020
Last Update
December 17 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. David Abramson
Englewood, New Jersey, United States, 07631
2
Dermatology, Laser & Vein Specialists of the Carolinas
Charlotte, North Carolina, United States, 28207